2chx
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:2chx.gif|left|200px]] | [[Image:2chx.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_2chx", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | | | + | or leave the SCENE parameter empty for the default display. |
| - | | | + | --> |
| - | + | {{STRUCTURE_2chx| PDB=2chx | SCENE= }} | |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-90''' | '''A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-90''' | ||
| Line 40: | Line 37: | ||
[[Category: Zunder, E R.]] | [[Category: Zunder, E R.]] | ||
[[Category: 3-kinase]] | [[Category: 3-kinase]] | ||
| - | [[Category: | + | [[Category: Inhibitor]] |
| - | [[Category: | + | [[Category: Kinase]] |
| - | [[Category: | + | [[Category: Lipid]] |
| - | [[Category: | + | [[Category: Phosphoinositide]] |
| - | [[Category: | + | [[Category: Quinazolinone]] |
| - | [[Category: | + | [[Category: Signaling]] |
| - | [[Category: | + | [[Category: Transferase]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 22:10:58 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 19:10, 3 May 2008
A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-90
Overview
Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined. We describe here an approach to pharmacologically interrogate the PI3-K family. A chemically diverse panel of PI3-K inhibitors was synthesized, and their target selectivity was biochemically enumerated, revealing cryptic homologies across targets and chemotypes. Crystal structures of three inhibitors bound to p110gamma identify a conformationally mobile region that is uniquely exploited by selective compounds. This chemical array was then used to define the PI3-K isoforms required for insulin signaling. We find that p110alpha is the primary insulin-responsive PI3-K in cultured cells, whereas p110beta is dispensable but sets a phenotypic threshold for p110alpha activity. Compounds targeting p110alpha block the acute effects of insulin treatment in vivo, whereas a p110beta inhibitor has no effect. These results illustrate systematic target validation using a matrix of inhibitors that span a protein family.
About this Structure
2CHX is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling., Knight ZA, Gonzalez B, Feldman ME, Zunder ER, Goldenberg DD, Williams O, Loewith R, Stokoe D, Balla A, Toth B, Balla T, Weiss WA, Williams RL, Shokat KM, Cell. 2006 May 19;125(4):733-47. Epub 2006 Apr 27. PMID:16647110 Page seeded by OCA on Sat May 3 22:10:58 2008
Categories: Homo sapiens | Single protein | Balla, A. | Balla, T. | Feldman, M E. | Goldenberg, D D. | Gonzalez, B. | Knight, Z A. | Loewith, R. | Shokat, K M. | Stokoe, D. | Toth, B. | Weiss, W A. | Williams, O. | Williams, R L. | Zunder, E R. | 3-kinase | Inhibitor | Kinase | Lipid | Phosphoinositide | Quinazolinone | Signaling | Transferase
